Trial intelligence / Profile preview

Tartarase for Dental Calculus Removal

NCT06139835Completed

Sponsor
Pontis Biologics, Inc.
Start
Jun 2022
Primary completion
Jul 2022
Modality
Therapeutic Enzymes
Countries
1
01

Overview

Randomised, single-blind trial of Tartarase in Dental calculus (3 arms), sponsored by Pontis Biologics, Inc. Primary endpoint: Tartarase Efficacy (Calculus using Volpe-Manhold Index) at 4 weeks. Started Jun 2022; status: completed.

02

Drugs

Tartarase
03

Conditions

Dental calculus

Beyond the preview

Go deeper on NCT06139835.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06139835.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call